Epsilon Healthcare Limited announced the appointment of two new directors of Epsilon, effective 1 August 2021. The new appointments bring significant experience to the Company across pharmaceuticals, research and development, operational optimisation, and supply chain logistics as the Company progresses towards being a toll and contract pharmaceutical manufacturer for the medicinal cannabis industry. Dr. Rob Jenny ­ experienced pharmaceutical executive ­ appointed an Executive Director under services agreement with Cannvalate. Mr. Simon Rowe ­ operational transformation and optimisation expert ­ appointed Non- Executive Director. Dr. Jenny and Mr. Rowe join Chairman Steven Xu towards delivering on new corporate initiatives introduced by the Senior Executive Team of Epsilon. Dr. Rob Jenny is currently an executive at Cannvalate, where he manages their business development activities in the Australian and New Zealand market. Mr. Simon Rowe is currently the Supply Chain Transformation & Operations Leader ANZ.